Uremic toxins: some thoughts on acrolein and spermine

Abstract

Chronic kidney disease (CKD) is characterized by the progressive reduction of glomerular filtration rate and subsequent retention of organic waste compounds called uremic toxins. While patients with CKD are at a higher risk of premature death due to cardiovascular complications, this increased risk cannot be completely explained by classical cardiovascular risk factors such as hypertension, diabetes mellitus, and obesity. Instead, recent research suggests that uremic toxins may play a key role in explaining this marked increase in cardiovascular mortality in patients with CKD. While spermine, a tetra-amine, has previously been hypothesized to act as an uremic toxin, the following review presents a summary of recent literature that casts doubt on this assertion. Instead, acrolein, an oxidative product of spermine and the triamine spermidine, is likely responsible for the toxic effects previously attributed to spermine.

Keywords:

• Chronic kidney disease
• uremia
• uremic toxins
• polyamines
• spermine
• end-stage renal disease
• uremic syndrome
• acrolein

Disclosure statement

The author reports no conflicts of interest. The author alone is responsible for the content and writing of this article.